Krishna Institute of Medical Sciences Ltd Share Price

Hospitals / Medical ServicesNSE
₹795.60
+27.80+3.62% (1D)
As on 20 Nov 2026 at 15:59
As of 20 Nov 2026 at 15:59, Krishna Institute of Medical Sciences Ltd is trading at ₹795.60. The 52-week range stands at ₹575.80–₹858.00, with a market cap of ₹33.48 thousand crore. At a P/E of 114.38 and a dividend yield of 0.00%, it is a large-cap stock in the Healthcare sector.

KIMS Price Chart

Market Cap
₹33.48K Cr
PE Ratio
114.38
ROCE
9.96%

Krishna Institute of Medical Sciences Ltd Performance

Krishna Institute of Medical Sciences Ltd Fundamentals

Know More
Market Cap₹33.48K Cr
ROE7.07%
P/E Ratio (TTM)114.38
EPS (TTM)₹6.97
P/B Ratio7.95
Dividend Yield0.00%
Industry P/E188.26
Book Value₹100.32
Debt to Equity0.17
Face Value₹2

Krishna Institute of Medical Sciences Ltd Shareholding Pattern

Know More
Promoter32.7%
Foreign Institutions15%
Mutual Funds28.2%
Domestic Institutions4.1%
Public20%

Krishna Institute of Medical Sciences Ltd Financial Statements

Know More
No data for this view.

Krishna Institute of Medical Sciences Ltd Peer Comparison

Know More
StocksLTP(₹)Market Cap(Cr)52 Week Low-High(₹)
Apollo Hospitals Enterprise Ltd
₹9,190.05
452.05(+5.17%)
1,32,138.86,696.5 - 9,282.5
Max Healthcare Institute Ltd
₹1,079.60
38.95(+3.74%)
1,05,080.4797.0 - 1,185.4
Manipal Health Enterprises Ltd
₹702.20
5.75(+0.83%)
92,365.8597.0 - 815.0
Aster DM Quality Care Ltd
₹779.65
40.35(+5.46%)
67,959.9519.1 - 891.3
Fortis Healthcare Ltd
₹825.00
15.15(+1.87%)
62,284.1705.0 - 1,010.1

About Krishna Institute of Medical Sciences

Krishna Institute of Medical Sciences Limited (KIMS) was erstwhile incorporated as Jagjit Singh and Sons Private Limited', a Private Limited Company on July 26, 1973 in Mumbai. Subsequently, the name of the Company changed to Krishna Institute of Medical Sciences Private Limited' on January 2, 2004 and further upon its conversion to a Public Company, the name was changed to Krishna Institute of Medical Sciences Limited' on January 29, 2004. The Company is one of the largest corporate groups in India, with hospitals in Telangana, Andhra Pradesh & Maharashtra providing multi-disciplinary integrated services with a focus on tertiary and quaternary healthcare at affordable cost. It is engaged in rendering medical and healthcare services. It operate 26 multispecialty hospitals under the 'KIMS Hospitals' brand, with an aggregate capacity of over 8600 beds. It offer a comprehensive range of healthcare services in over 40 specialties and super specialties, including cardiac sciences, oncology, neurosciences, gastric sciences, orthopaedics, organ transplantation, renal sciences and mother & child care. Until the year 2003, the Company was owned, managed and controlled by Jagjit Singh and certain of his family members, who together owned the entire shareholding of the Company. In February 2003, acting in pursuance of the Takeover MoU, certain of its Promoters, namely Dr. Bhaskar Rao Bollineni, Krishnaiah Bollineni and BRMH, along with certain other individuals and entities, acquired the entire equity share capital of the Company. Led by Dr. Bhaskar Rao Bollineni, Managing Director and CEO of the Company, a renowned cardiothoracic surgeon, it has grown from a single hospital to a chain of multispecialty hospitals, both organically and through strategic acquisitions. The oldest hospital in their network was established in 2000 at Nellore, by its Corporate Promoter, BRMH, with a capacity of approximately 200 beds and, At present, the hospital network has grown to six multispecialty hospitals in six cities, with a total capacity of 4000 beds, including 1,705 operational beds. The Hospitals are equipped with state-of-the-art medical equipment and employ practices and policies which help to provide quality healthcare services to their patients. It was one of the first hospitals in Hyderabad to install 4-Arm HD da Vinci Robot technology at Secunderabad hospital. The flagship hospitals at Secunderabad and Rajahmundry have been accredited by the National Accreditation Board for Hospitals and Healthcare Providers, India ('NABH'). The Hospital at Secunderabad is accredited with ISO 9001:2008 certification and has also been accredited by the National Accreditation Board for Testing and Calibration Laboratories ('NABL'). The Hospital situated at Secunderabad was awarded the Healthcare Excellence Award', by the Indo Global Healthcare Summit and Expo, in 2015. It has also received awards from the Association of Healthcare Providers (India) ('AHPI') for nursing excellence, in 2015 and for Patient Friendly Hospital', in 2017. In 2017, it was awarded the best hospital of the year in the multispecialty hospital category in Hyderabad by Times Healthcare Achievers Awards and in 2016 received the Pharmacie DeQualite certification from Bureau Veritas. Further, it was the first hospital in Andhra Pradesh and Telangana to have been Green OT certified in 2016. It is also the laureate of the Asia Pacific Society of Infection Control CSSD Center of Excellence Silver Award 2015-2016. Neurology India Journal has ranked the neurology department at its hospital at Secunderabad as the third biggest centre in India on the basis of volume of epilepsy surgeries performed, as on July 31, 2016. In addition to healthcare services, the company also conduct medical education programmes through its affiliations with state medical boards and universities, for various broad and super specialties at its hospitals in Secunderabad and Rajahmundry, including for DNB, under graduation, post-graduation, PhD and diploma programmes. It is also affiliated with Kaloji Narayana Rao University of Health Sciences and the Andhra Pradesh Para Medical Board. During 2022, Sunshine Hospitals became subsidiary of the Company effective from April, 2022. In 2022-23, the Company opened an exclusive Gastroenterology unit at Vizag. During FY 2022-23, Sarvejana Healthcare Private Limited became a Subsidiary of the Company effective 01st April 2022; SPANV Medisearch Lifesciences Private Limited became the Subsidiary of Company on 01.09.2022. Suryateja Healthcare Private Limited has ceased to be step down subsidiary of the Company w.e.f. December 01, 2022. The Nagpur Hospital became functional in 2024. The Company acquired a running hospital of 200 beds-QUEENS NRI HOSPITAL in Vizag, Andhra Pradesh in Jul'24. In Kerala, the hospitals at Kannur and Kollam, commissioned in October 2024. The Company opened its first liver transplantation in Rayalaseema region in Andhra Pradesh took place in KIMS hospitals at Kurnool. Similarly, another liver transplantation took place at KIMS in Srikakulam in 2025. Company launched a 300-bed facility in Thane, Mumbai in April 2025. It launched the second unit, at Seethammadhara, with a fertility centre, Paediatric and Childcare unit and a specialty care centre. In 2026, the Company launched two super-specialty hospitals in Mahadevapura and Electronic City in Bengaluru by adding 800 beds, 30 operation theatres, more than 170 outpatient consultation rooms and 25 Centres of Excellence. At the same time, it expanded the existing network with the commissioning of a 200 bed multi-specialty facility in Kompally, Hyderabad.

Parent Organisation—
Founded1973
Managing DirectorBhaskara Rao Bollineni
NSE SymbolKIMS

Krishna Institute of Medical Sciences Ltd Resistance and Support levels

R3779.90R2773.81R1770.04S1757.86S2754.09S3748.00795.60

Krishna Institute of Medical Sciences Ltd Technicals

Current Price
₹795.60 ₹27.80 (+3.62%)
Bearish
0
Bullish
12
  • 20 Day8.4%
  • 50 Day8.2%
  • 100 Day7.0%
  • 200 Day8.5%

Krishna Institute of Medical Sciences Ltd Latest News

View More
04 NOV 2026 | Wednesday
KIMS Limited approved merger with KIMS Hospitals to streamline corporate structure
04 NOV 2026 | Wednesday
Krishna Institute re-appoints Bollineni and Rao to leadership roles for five years
29 OCT 2026 | Thursday
KIMS acquires 5.82% stake in Ushahkal Abhinav Specialty Hospital for Rs 15 crore
29 OCT 2026 | Thursday
KIMS to acquire 51% stake in Sarvottam Health Care for up to Rs 80 crore
26 OCT 2026 | Monday
Krishna Institute to review Q2 financial results at board meeting November 4, 2026
10 OCT 2026 | Saturday
Krishna Institute of Medical Sciences Limited files regulatory certificate with MUFG Intime India
06 OCT 2026 | Tuesday
Krishna Institute of Medical Sciences to acquire up to 22% stake in Splendid Hospitals
06 OCT 2026 | Tuesday
Krishna Institute to acquire 51% stake in Sarvottam Health Care for up to Rs 80 crore
06 OCT 2026 | Tuesday
KIMS to acquire 6% stake in Ushahkal Abhinav Specialty Hospital for up to Rs 15 crore
06 OCT 2026 | Tuesday
KIMS to acquire up to 51% stake in Insignia Healthcare for Rs 30.35 per share

2026

Quarterly ResultRelease dateCheck Latest financial
Quarterly ResultRelease dateCheck Latest financial
Board MeetingAnnounced
Quarterly ResultRelease dateCheck Latest financial
Board MeetingAnnounced
Quarterly ResultRelease dateCheck Latest financial

Frequently asked questions

The share price of Krishna Institute of Medical Sciences Ltd is ₹795.60 as of 20 Nov 2026 at 15:59.

Not sure where to start?

Book a free 30-minute consultation with our investment experts today!

Invest Now